PUBLIC COMPANY
saveABIONYX Pharma SA
founded 2005 · 8 employees · Balma, Occitanie, FRupdated 2mo ago
ABIONYX Pharma is a French biotech developing HDL-based therapies for renal and ophthalmological diseases, with a lead asset CER-001 (a recombinant apoA-I-based HDL-mimetic) and a platform of HDL vectors for targeted drug delivery. The company was renamed from Cerenis Therapeutics in August 2019 and is listed on Euronext Paris under the ticker ABNX.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that